Vanessa C. Williams

Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D₄–Receptor Antagonist

Patrick Manning, Richard M. Watson, Dorothy J. Margolskee et al. · New England Journal of Medicine · 1990 · 401 citations · Full text

Life Sciences, Pharmacology, Exercise Physiology +8

Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study

Grace A. McComsey, Douglas Ward, Siegrid M. Hessenthaler et al. · Clinical Infectious Diseases · 2004 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

Grace A. McComsey, D. Paulsen, J Tyler Lonergan et al. · AIDS · 2004 · 171 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Bronchodilation with a Potent and Selective Leukotriene D4 (LTD4) Receptor Antagonist (MK-571) in Patients with Asthma

Joseph N. Gaddy, Dorothy J. Margolskee, Robert K. Bush et al. · American Review of Respiratory Disease · 1992 · 141 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study

Marinus H. J. van Oers, Kazimierz Kuliczkowski, Lukáš Smolej et al. · The Lancet Oncology · 2015 · 112 citations

Medicine, Hematology, Oncology +15